INTRODUCTION: Racial/ethnic health disparities are well documented, yet little is known about the effect of fertility treatment on disparities. This study assesses the relationship between fertility treatment and adverse neonatal outcomes by race/ethnicity. METHODS: A secondary data analysis was performed using National Vital Statistics (2012–2020) including singleton, non-anomalous births from 23 to 42 weeks of gestation. The primary outcome was an adverse neonatal composite outcome (ANCO) encompassing neonatal intensive care unit admission, assisted ventilation, seizures, and Apgar scores less than 7 at 5 minutes. Multivariable logistic regression assessed whether fertility treatment was associated with ANCO by race/ethnicity after adjusting for maternal age, gestational age at delivery, maternal body mass index, education status, insurance, and delivery year. RESULTS: Of 31,975,746 births meeting inclusion criteria, 414,716 (1.3%) were conceived with fertility treatment. Across the entire cohort, fertility treatment was associated with significantly increased odds of ANCO (adjusted odds ratio [aOR] 1.44; 95% CI, 1.43–1.46). Prevalence of ANCO was highest for the non-Hispanic Black (NHB) and American Indian/Alaska Native (AIAN) populations in both nonfertility and fertility treatment groups. Without fertility treatment, the Asian/Pacific Islander (API) and Hispanic groups had the lowest rates of ANCO at 8.3% and 8.9%, respectively. With fertility treatment, ANCO odds increased the most in API (aOR 1.61; 1.56–1.66) and Hispanic populations (aOR 1.60; 1.54–1.65). CONCLUSION: Fertility treatment is associated with approximately 1.5 times the odds of adverse neonatal outcomes across all racial/ethnic groups, with the greatest increase among the API and Hispanic populations. The NHB and AIAN groups experienced the highest overall rates of ANCO, supporting the need for targeted interventions for historically marginalized populations.